Clinical trials
Phase 3 Vascular Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
62 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2008 | 6 |
| 2009 | 7 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 3 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 4 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 47 |
| Terminated | 5 |
| Unknown status | 3 |
| Active, not recruiting | 3 |
| Withdrawn | 1 |
| Enrolling by invitation | 1 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | 12 |
| Takeda | 6 |
| Abbott Medical Devices | 4 |
| United Therapeutics | 3 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Merck Sharp & Dohme LLC | 2 |
| Novartis Pharmaceuticals | 2 |
| University of South Florida | 2 |
| Abiomed Inc. | 1 |
| Amarin Pharma Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Vascular Diseases | 62 |
| Cardiovascular Diseases | 40 |
| Hypertension | 29 |
| Heart Diseases | 25 |
| Myocardial Ischemia | 9 |
| Coronary Artery Disease | 8 |
| Coronary Disease | 7 |
| Hypertension, Pulmonary | 6 |
| Lung Diseases | 6 |
| Stroke | 6 |
Trials
Showing 1 to 25 of 62. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.